Cheapest Semaglutide Online in 2026: What You'll Actually Pay

Wegovy at a retail pharmacy costs approximately $1,350–$1,650/month without insurance (GoodRx retail pricing). Compounded semaglutide, the same active ingredient prepared by licensed compounding pharmacies, starts at $99/month all-inclusive. That gap exists because compounding pharmacies operate outside the standard drug approval process, cutting out brand-name manufacturing costs and pharmacy markups. Compounded semaglutide is not FDA-approved as a finished product, but it has become the primary route for uninsured patients searching for the lowest price.

One middle-ground option worth knowing about: Novo Nordisk offers Wegovy directly through their own self-pay program. The injectable pen is $199/month for the first two fills at starter doses (offer runs through December 31, 2026), stepping up to $349/month afterward ($399/month for the 7.2mg Wegovy HD dose), and the Wegovy pill is priced by dose, from $149/month at 1.5mg up to $199/month at 4mg and $299/month at 9mg and 25mg. See wegovy.com for current pricing, which is actively changing.

Last verified: October 2026 by RxPickr Editorial Team. Monthly prices below were confirmed against each provider's public pricing page in our October 2026 pricing refresh, except TrimRx, Oak Longevity, bmiMD, and MEDVi, whose sites blocked our checks this cycle; their compounded prices are carried forward from our September 1 check (MEDVi's oral refill rate from an earlier check; see the pricing tool for per-entry dates). We re-verify pricing monthly. Our full methodology is at How we rate providers.

The real cost breakdown

The table below is generated from our live pricing database, the same October-2026-verified data that powers the RxPickr pricing tool, so it stays current as we re-verify each provider every month. The monthly cost shown is the true total: medication plus any required membership. First-month promo rates are excluded so you see what you'd actually pay ongoing.

Eden is now the cheapest compounded semaglutide we track, month to month: it dropped its separate membership for compounded medication and charges $99/mo all-inclusive at every dose, with no intro rate and no commitment. Eden's page says the price is not introductory and advertises a lifetime price guarantee; that is Eden's claim, not ours, so confirm it at checkout. bmiMD's $119/mo and Oak Longevity's $133/mo in the table both require paying for several months upfront (bmiMD is $159/mo month to month). Mochi Health switched to per-dose pricing in August 2026: its compounded semaglutide starts at $139/mo total ($60 medication plus its $79 membership) at the lowest dose, climbing to $178/mo at the highest dose. For other flat rates, Shed cut its full-dose compounded semaglutide to $159/mo on the 12-month plan ($199/mo month to month), Shed Microdose is $149/mo all-inclusive, and Found's restructured all-in plan is $169/mo (12-month plan, compounded medication included; $289/mo month-to-month). Oak Longevity's compounded semaglutide is confirmed at $133/mo on a 3-month supply with its checkout code ($200/mo without it). Henry Meds' "$179" applies to their sublingual sema (or liraglutide injection), not the compounded sema injection, which is $297/mo on month-to-month (or $197/mo on a 12-month paid-in-full commitment of $2,364). TrimRx charges a flat $199/mo at every dose; its "$179" headline is a first-month rate on the month-to-month plan, which renews at $299/mo (prepaid plans run $174–$209/mo). Watch first-month promo rates generally: MEDVi's $179 first month (carried from September) has reportedly jumped to $299 on refill. Mochi Health's split-billing model adds dietitian and unlimited physician access; more on that distinction below.

Why compounded semaglutide costs less

Compounding pharmacies operate under a different regulatory model than pharmaceutical manufacturers. Rather than seeking pre-market FDA approval for a drug product, they prepare medications on a per-patient or batch basis under state pharmacy board oversight and, for 503B facilities, under FDA registration as outsourcing facilities subject to Current Good Manufacturing Practice (CGMP) standards.

The cost savings come from several places. There's no multi-year clinical trial cost built into the price. There's no pharmaceutical marketing spend. And compounders can source the active ingredient (semaglutide API) and produce a finished vial without the brand premium attached to Wegovy's auto-injector pens.

What compounded semaglutide is not: it is not FDA-approved as a finished product. It uses the same active ingredient as Wegovy and Ozempic, but has not gone through the FDA's drug approval process for the final formulation. This distinction matters: published clinical trials for Wegovy involved tens of thousands of patients across rigorous randomized controlled trials; compounded semaglutide formulations have not undergone equivalent large-scale trials.

The compounding legal landscape has shifted: what to know in 2026

The regulatory situation for compounded semaglutide has changed significantly since 2024, and it's worth understanding before you choose a provider.

During the semaglutide shortage, the FDA allowed 503B outsourcing facilities to produce compounded semaglutide under shortage provisions. The FDA declared the shortage resolved in early 2025 (FDA drug shortage database). On April 1, 2026, the FDA issued a formal clarification: 503B facilities may only compound using bulk drug substances that appear on the FDA's 503B bulks list or that are actively on the shortage list. Since semaglutide currently meets neither condition, 503B facilities face significant legal restrictions on compounding it (FDA statement, April 2026).

503A pharmacies (traditional compounding pharmacies that compound for individual patients on a per-prescription basis) are in a different position and continue to operate legally in most states.

Novo Nordisk has also taken aggressive enforcement action: as of August 2025, the company had filed 132 complaints in federal courts across 40 states against telehealth companies and compounding pharmacies marketing compounded semaglutide, with courts issuing 44 permanent injunctions in related cases (Novo Nordisk press release, August 5, 2025).

What this means practically: some providers using 503B facilities may face disruptions; others have transitioned to 503A-based supply chains. Before ordering, confirm which type of pharmacy your provider uses and whether they have received any FDA or legal notices. A reputable provider will be transparent about this.

What to watch out for

Many providers display headline prices that don't reflect what you'll actually pay at checkout. Here's where the gaps appear.

Separate membership fees. Mochi Health charges $79/month for membership plus a per-dose medication price that runs $60/month at the lowest dose up to $99/month at the highest, so the total ranges from $139 to $178/month. Ro charges a $149/month membership fee on top of medication costs ($74/mo on annual). Hers requires a $149/mo Weight Loss Membership on top of medication. Found and Eden used to bill this way for compounded medications but have folded the drug into one all-in price (Eden still requires its $99/month membership for brand-name medications). These split-billing models can still beat brand-name pricing but aren't the single number some providers advertise.

Dose escalation costs. Some providers price compounded semaglutide on a tiered basis where higher doses cost more. Mochi Health moved to per-dose pricing in August 2026, with semaglutide running $60/month at the lowest dose up to $99/month at the highest, before its $79/month membership. Shed's product pages no longer describe dose-based increases on its full-dose injection plan, so confirm current pricing at checkout. Found, TrimRx, Eden, Enhance.MD, Oak Longevity, and Henry Meds still hold a flat medication rate across all doses. Ask your provider directly what the price looks like at maintenance doses before committing, since that's what you'll pay long-term.

Initial consultation fees. Some providers charge a separate one-time intake or consultation fee. PlushCare charges a separate initial visit fee on top of the membership. Confirm whether the advertised monthly price includes your first consultation or bills it separately.

Shipping and supply costs. All-inclusive providers like Henry Meds and TrimRx include needles, syringes, and shipping. Others may bill supplies separately, adding $10 to $30/month.

How to get the lowest price

A few concrete steps that reduce what you pay.

Ask about all-inclusive pricing before you sign up. The first question to any provider: does this monthly price cover medication, supplies, shipping, and follow-up visits? If the answer involves any "plus membership" language, you need to add those numbers together before comparing.

Avoid providers with separate membership fees if cost is your primary concern. Unless the membership adds something you'll actually use, like unlimited dietitian access from Mochi Health, a separate membership is a cost with no direct medication value. For pure price minimization, Eden (compounded products), Shed (compounded products), Oak Longevity, TrimRx, Enhance.MD, Noom Med, and Found's all-in compounded plan are structured without separate memberships.

Confirm the pharmacy is a licensed 503A or 503B facility and verify current legal status. Not all compounding pharmacies meet the same quality standards. 503B outsourcing facilities are registered with the FDA and subject to CGMP oversight, though their ability to compound semaglutide is now legally restricted (see above). 503A pharmacies compound for individual patients and face different rules. Your provider should be transparent about which type of pharmacy they use. You can search for registered 503B facilities on the FDA's 503B list.

Check GoodRx as a brand-name fallback. If compounded semaglutide isn't available in your state, or if you prefer brand-name, GoodRx coupons can sometimes reduce Wegovy's retail price to $800–$1,000/month depending on pharmacy. This is still much more than compounded options, but worth knowing if your only alternative is full retail pricing. Visit goodrx.com and search for semaglutide.

Check Novo Nordisk's self-pay program directly. Wegovy pen self-pay pricing is $199/month for the first two fills at starter doses (through December 31, 2026), then $349/month afterward; the Wegovy pill is priced by dose, from $149/month at 1.5mg up to $299/month at 9mg and 25mg (the earlier $149-for-4mg rate ended August 31, 2026). Check wegovy.com directly for current eligibility and pricing, as these programs are evolving.

Consult your healthcare provider before starting any GLP-1 medication. Your clinical history, current medications, and health goals all factor into whether semaglutide is appropriate for you and which formulation makes sense.